Cellomics International Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
32
- Latest Deal Type
-
Later Stage VC
- Investors
-
7
Cellomics International General Information
Description
Operator of the biotech company focusing on the development of biopsy products and services intended for the treatment of cancer. The company offers services such as cutting edge technology, companion diagnosis, sorting platform and real-time monitoring, helping doctors and patients in the management and early detection of cancer.
Contact Information
Website
www.cellomicsbio.comCorporate Office
- 2nd Floor, Block A, Langwei Village, Number 16 Baoshan Road, Liulian Community
- Pingshan Subdistrict Office, Pingshan District
- Shenzhen, Guangdong 518118
- China
Corporate Office
- 2nd Floor, Block A, Langwei Village, Number 16 Baoshan Road, Liulian Community
- Pingshan Subdistrict Office, Pingshan District
- Shenzhen, Guangdong 518118
- China
Cellomics International Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Later Stage VC | 01-Oct-2024 | Completed | Generating Revenue | |||
| 5. Later Stage VC | 09-Nov-2023 | Completed | Generating Revenue | |||
| 4. Later Stage VC (Series B1) | 03-Jul-2023 | Completed | Generating Revenue | |||
| 3. Later Stage VC | 01-Mar-2022 | Completed | Generating Revenue | |||
| 2. Later Stage VC (Series B) | 24-Sep-2021 | Completed | Generating Revenue | |||
| 1. Accelerator/Incubator | 22-Apr-2019 | Completed | Generating Revenue |
Cellomics International Signals
Cellomics International Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Hong Kong Science & Technology Parks | Accelerator/Incubator | Minority | ||
| China Taiping Insurance Investment | Corporate Venture Capital | Minority | ||
| Beyond Ventures | Venture Capital | Minority | ||
| Jacobson Pharma | Corporation | Minority | ||
| Raffles Family Office | Family Office | Minority |
Cellomics International FAQs
-
When was Cellomics International founded?
Cellomics International was founded in 2018.
-
Where is Cellomics International headquartered?
Cellomics International is headquartered in Shenzhen, China.
-
What is the size of Cellomics International?
Cellomics International has 32 total employees.
-
What industry is Cellomics International in?
Cellomics International’s primary industry is Diagnostic Equipment.
-
Is Cellomics International a private or public company?
Cellomics International is a Private company.
-
What is Cellomics International’s current revenue?
The current revenue for Cellomics International is .
-
Who are Cellomics International’s investors?
Hong Kong Science & Technology Parks, China Taiping Insurance Investment, Beyond Ventures, Jacobson Pharma, and Raffles Family Office are 5 of 7 investors who have invested in Cellomics International.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process